Chemoinformaics analysis of 12alpha-Hydroxyevodol
| Molecular Weight | 500.5 | nRot | 1 |
| Heavy Atom Molecular Weight | 472.276 | nRig | 36 |
| Exact Molecular Weight | 500.168 | nRing | 7 |
| Solubility: LogS | -4.855 | nHRing | 5 |
| Solubility: LogP | 1.392 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 5 |
| nHA | 10 | APOL | 70.1102 |
| nHD | 2 | BPOL | 39.3738 |
| QED | 0.34 |
| Synth | 6.331 |
| Natural Product Likeliness | 3.349 |
| NR-PPAR-gamma | 0.63 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.997 |
| Pgp-sub | 0.166 |
| HIA | 0.02 |
| CACO-2 | -5.341 |
| MDCK | 0.0000325 |
| BBB | 0.32 |
| PPB | 0.674327 |
| VDSS | 0.861 |
| FU | 0.286268 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.132 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.419 |
| CYP2c9-inh | 0.042 |
| CYP2c9-sub | 0.01 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.099 |
| CYP3a4-inh | 0.433 |
| CYP3a4-sub | 0.294 |
| CL | 7.073 |
| T12 | 0.62 |
| hERG | 0.028 |
| Ames | 0.267 |
| ROA | 0.922 |
| SkinSen | 0.213 |
| Carcinogencity | 0.32 |
| EI | 0.108 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.496 |
| Antiviral | Yes |
| Prediction | 0.837737 |